Axillary Lymph Node Ultrasound Following Neoadjuvant Chemotherapy in Biopsy-Proven Node-Positive Breast Cancer: Results from the SN FNAC Study-Reference-Cited by-同舟云学术

Axillary Lymph Node Ultrasound Following Neoadjuvant Chemotherapy in Biopsy-Proven Node-Positive Breast Cancer: Results from the SN FNAC Study

Published:2019-10-11 Issue:13 Volume:26 Page:4337-4345
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Morency Dominique,Dumitra Sinziana,Parvez Elena,Martel Karyne,Basik Mark,Robidoux André,Poirier Brigitte,Holloway Claire M. B.,Gaboury Louis,Sideris Lucas,Meterissian Sarkis,Boileau Jean-François

Funder

Quebec Breast Cancer Foundation

Montreal Jewish General Segal Cancer Centre

Week-end to End Women's Cancers

Cancer Research Society

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/content/pdf/10.1245/s10434-019-07809-7.pdf

Reference21 articles.

1. Fleissig A, Fallowfield LJ, Langridge CI, et al. Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer. Breast Cancer Res Treat. 2006;95(3):279–93.

2. Krag DN, Anderson SJ, Julian TB, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010;11(10):927–33.

3. National Comprehensive Cancer Network. Breast Cancer (Version 3.2018) (2018). https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf . Accessed 12 Jan 2019.

4. Krag DN, Anderson SJ, Julian TB, et al. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol. 2007;8(10):881–8.

5. Geng C, Chen X, Pan X, Li J. The feasibility and accuracy of sentinel lymph node biopsy in initially clinically node-negative breast cancer after neoadjuvant chemotherapy: a systematic review and meta-analysis. PLoS ONE 2016;11(9):e0162605.

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nomogram Based on US and Clinicopathologic Characteristics: Axillary Nodal Evaluation Following Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer;Clinical Breast Cancer;2024-08

2. Micrometastases in axillary lymph nodes in breast cancer, post-neoadjuvant systemic therapy;Breast Cancer Research;2024-07-31

3. Micrometastases in axillary lymph nodes in breast cancer, post-neoadjuvant systemic therapy;2024-05-16

4. Oncologic Outcomes for Different Axillary Staging Techniques in Patients with Nodal-Positive Breast Cancer Undergoing Neoadjuvant Systematic Treatment: A Cancer Registry Study;Annals of Surgical Oncology;2024-05-06

5. Can Axillary Ultrasound Identify Node Positive Patients Who can Avoid an Axillary Dissection After Neoadjuvant Chemotherapy?;Journal of Surgical Research;2024-01